Trademark Search  /  OPTICYTE

OPTICYTE

● Live · Registered

U.S. federal trademark · Serial No. 90025742 · Reg. No. 6256450

Mark
OPTICYTE
Status
Registered
Serial Number
90025742
Registration No.
6256450
Filing Date
June 29, 2020
Registration Date
January 26, 2021
Class(es)
Class 005

Owners

MERAKRIS THERAPEUTICS, INC.
03 · RESEARCH TRIANGLE PARK, NC
Merakris Therapeutics, LLC
16 · Research Triangle Park, NC
Merakris Therapeutics, LLC
16 · Research Triangle Park, NC
Merakris Therapeutics, LLC
16 · Research Triangle Park, NC

Goods & Services

Human biological amniotic membrane or other postpartum tissues intended for subsequent implantation; human biological amniotic tissue or other postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment or prevention of ophthalmic diseases, or the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; human biological tissue, namely, placental-derived tissue for use in biological tissue grafts for use in surgery and wound repair involving the eye; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye, and the treatment or prevention of ophthalmic diseases; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions involving the eye; wound treatment in the nature of amniotic material prepared in sheet forms or viscous forms

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "OPTICYTE" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.